Genetic modifiers and oligogenic inheritance

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 6, 2015, Pages 1-22

  Kousi, Maria ^a   Katsanis, Nicholas ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ALLELE; ARTICLE; CLINICAL EVALUATION; EXOME; GENE FREQUENCY; GENE INTERACTION; GENE LOCUS; GENE MAPPING; GENETIC HETEROGENEITY; HUMAN; INDUCED MUTATION; INHERITANCE; LONGITUDINAL STUDY; MODIFIER GENE; MOLECULAR CLONING; NONHUMAN; RETINA DEGENERATION; ANIMAL; BIOLOGICAL MODEL; FORECASTING; GENETICS; INBRED MOUSE STRAIN; MOUSE; MULTIFACTORIAL INHERITANCE; MUTATION; PENETRANCE; PHENOTYPE;

ALLELES; ANIMALS; CLONING, MOLECULAR; FORECASTING; GENES, MODIFIER; HUMANS; MICE; MICE, INBRED STRAINS; MODELS, GENETIC; MULTIFACTORIAL INHERITANCE; MUTATION; PENETRANCE; PHENOTYPE; RETINAL DEGENERATION;

EID: 84930389652     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a017145     Document Type: Article

References (153)

1. Ackermann B, Kröber S, Torres-Benito L, Borgmann A, Peters M, Hosseini Barkooie SM, Tejero R, Jakubik M, Schreml J, Milbradt J, et al. 2013. Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality. Hum Mol Genet 22: 1328-1347.
2. Akhmedov NB, Piriev NI, Chang B, Rapoport AL, Hawes NL, Nishina PM, Nusinowitz S, Heckenlively JR, Roderick TH, Kozak CA, et al. 2000. A deletion in a photoreceptor-specific nuclear receptor mRNA causes retinal degeneration in the rd7 mouse. Proc Natl Acad Sci 97: 5551-5556.
3. Anderson M, Smith R, Savinova O, Hawes N, Chang B, Zabaleta A, Wilpan R, Heckenlively J, Davisson M, John S. 2001. Genetic modification of glaucoma associated phenotypes between AKXD-28/Ty and DBA/2J mice. BMC Genet 2: 1.
4. Apfelstedt-Sylla E, Theischen M, Rüther K, Wedemann H, Gal A, Zrenner E. 1995. Extensive intrafamilial and interfamilial phenotypic variation among patients with autosomal dominant retinal dystrophy and mutations in the human RDS/peripherin gene. Br J Ophthalmol 79: 28-34.
5. Arts HH, Doherty D, van Beersum SEC, Parisi MA, Letteboer SJF, Gorden NT, Peters TA, Marker T, Voesenek K, Kartono A, et al. 2007. Mutations in the gene encoding the basal body protein RPGRIP1L, a nephrocystin-4 interactor, cause Joubert syndrome. Nat Genet 39: 882-888.
6. Astuto LM, Bork JM, Weston MD, Askew JW, Fields RR, Orten DJ, Ohliger SJ, Riazuddin S, Morell RJ, Khan S, et al. 2002. CDH23 mutation and phenotype heterogeneity: A profile of 107 diverse families with Usher Syndrome and nonsyndromic deafness. Am J Hum Genet 71: 262-275.
7. Baala L, Audollent S, Martinovic J, Ozilou C, Babron M-C, Sivanandamoorthy S, Saunier S, Salomon R, Gonzales M, Rattenberry E, et al. 2007. Pleiotropic effects of CEP290 (NPHP6) mutations extend to Meckel syndrome. Am J Hum Genet 81: 170-179.
8. Badano JL, Katsanis N. 2002. Beyond Mendel: An evolving view of human genetic disease transmission. Nat Rev Genet 3: 779-789.
9. Badano JL, Kim JC, Hoskins BE, Lewis RA, Ansley SJ, Cutler DJ, Castellan C, Beales PL, Leroux MR, Katsanis N. 2003. Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic effect on Bardet-Biedl patients with two mutations at a second BBS locus. Hum Mol Genet 12: 1651-1659.
10. Badano JL, Mitsuma N, Beales PL, Katsanis N. 2006. The ciliopathies: An emerging class of human genetic disorders. Annu Rev Genomics Hum Genet. 7: 125-148.
11. Beales PL, Elcioglu N, Woolf AS, Parker D, Flinter FA. 1999. New criteria for improved diagnosis of Bardet-Biedl syndrome: Results of a population survey. J Med Genet 36: 437-446.
12. Beales PL, Badano JL, Ross AJ, Ansley SJ, Hoskins BE, Kirsten B, Mein CA, Froguel P, Scambler PJ, Lewis RA, et al. 2003. Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome. Am J Hum Genet 72: 1187-1199.
13. Bernstein PS, Tammur J, Singh N, Hutchinson A, Dixon M, Pappas CM, Zabriskie NA, Zhang K, Petrukhin K, Leppert M, et al. 2001. Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene. Invest Ophthalmol Vis Sci 42: 3331-3336.
14. Bolk S, Pelet A, Hofstra RMW, Angrist M, Salomon R, Croaker D, Buys CHCM, Lyonnet S, Chakravarti A. 2000. A human model for multigenic inheritance: Phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc Natl Acad Sci 97: 268-273.
15. Bolz H, von Brederlow B, Ramirez A, Bryda EC, Kutsche K, Nothwang HG, Seeliger M, Cabrera MdCS, Vila MC, Molina OP, et al. 2001. Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D. Nat Genet 27: 108-112.
16. Bone-Larson C, Basu S, Radel JD, Liang M, Perozek T, Kapousta-Bruneau N, Green DG, Burmeister M, Hankin MH. 2000. Partial rescue of the ocular retardation phenotype by genetic modifiers. J Neurobiol 42: 232-247.
17. Borrego S, Ruiz A, Saez ME, GimmO, Gao X, López-Alonso M, Hernández A, Wright FA, Antiñolo G, Eng C. 2000. RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease. J Med Genet 37: 572-578.
18. Boylan JP, Wright AF. 2000. Identification of a novel protein interacting with RPGR. Hum Mol Genet 9: 2085-2093.
19. Brattgard S. 1949. The pathology of the Laurence-Moon-Biedl syndrome. Acta Path Microbiol Scand 26: 525-537.
20. Brenman JE, Topinka JR, Cooper EC, McGee AW, Rosen J, Milroy T, Ralston HJ, Bredt DS. 1998. Localization of postsynaptic density-93 to dendritic microtubules and interaction with microtubule-associated protein 1A. J Neurosci 18: 8805-8813.
21. Carmi R, Elbedour K, Stone EM, Sheffield VC. 1995. Phenotypic differences among patients with Bardet-Biedl syndrome linked to three different chromosome loci. Am J Med Genet 59: 199-203.
22. Carrasquillo MM, McCallion AS, Puffenberger EG, Kashuk CS, Nouri N, Chakravarti A. 2002. Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat Genet 32: 237-244.
23. Chang B, Smith RS, Hawes NL, Anderson MG, Zabaleta A, SavinovaO, Roderick TH, Heckenlively JR, DavissonMT, John SWM. 1999. Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet 21: 405-409.
24. Chang B, Khanna H, Hawes N, Jimeno D, He S, Lillo C, Parapuram SK, Cheng H, Scott A, Hurd RE, et al. 2006. In-frame deletion in a novel centrosomal/ciliary protein CEP290/NPHP6 perturbs its interactionwith RPGR and results in early-onset retinal degeneration in the rd16 mouse. Hum Mol Genet 15: 1847-1857.
25. Chen J, Simon MI, Matthes MT, Yasumura D, LaVail MM. 1999. Increased susceptibility to light damage in an arrestin knockout mouse model of Oguchi disease (stationary night blindness). Invest Ophthalmol Vis Sci 40: 2978-2982.
26. Church C, Moir L, McMurray F, Girard C, Banks GT, Teboul L, Wells S, Bruning JC, Nolan PM, Ashcroft FM, et al. 2010. Overexpression of Fto leads to increased food intake and results in obesity. Nat Genet 42: 1086-1092.
27. Coleman DL, Eicher EM. 1990. Fat (fat) and tubby (tub): Two autosomal recessive mutations causing obesity syndromes in the mouse. J Hered 81: 424-427.
28. Coppieters F, Casteels I, Meire F, De Jaegere S, Hooghe S, van Regemorter N, Van Esch H, Matulevičienė A, Nunes L, Meersschaut V, et al. 2010. Genetic screening of LCA in Belgium: Predominance of CEP290 and identification of potential modifier alleles in AHI1 of CEP290-related phenotypes. Hum Mutat 31: E1709-E1766.
29. Cutting GR. 2010. Modifier genes in Mendelian disorders: The example of cystic fibrosis. Ann NY Acad Sci 1214: 57-69.
30. Czeizel AE, Dudás I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327: 1832-1835.
31. Danciger M, Matthes MT, Yasamura D, Akhmedov NB, Rickabaugh T, Gentleman S, Redmond TM, La Vail MM, Farber DB. 2000. A QTL on distal Chromosome 3 that influences the severity of light-induced damage to mouse photoreceptors. Mamm Genome 11: 422-427.
32. Danciger M, Ogando D, Yang H, Matthes MT, Yu N, Ahern K, Yasumura D, Williams RW, LaVail MM. 2008. Genetic modifiers of retinal degeneration in the rd3 mouse. Invest Ophthalmol Vis Sci 49: 2863-2869.
33. Darrah R, McKone E, O'Connor C, Rodgers C, Genatossio A, McNamara S, Gibson R, Stuart Elborn J, Ennis M, et al. 2010. EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severity. Physiol Genomics 41: 71-77.
34. Davis EE, Katsanis N. 2012. The ciliopathies: A transitional model into systems biology of human genetic disease. Curr Opin Genet Dev 22: 290-303.
35. Delous M, Baala L, Salomon R, Laclef C, Vierkotten J, Tory K, Golzio C, Lacoste T, Besse L, Ozilou C, et al. 2007. The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome. Nat Genet 39: 875-881.
36. den Hollander AI, Koenekoop RK, Yzer S, Lopez I, Arends ML, Voesenek KEJ, Zonneveld MN, Strom TM, Meitinger T, Brunner HG, et al. 2006. Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis. Am J Hum Genet 79: 556-561.
37. den Hollander AI, Roepman R, Koenekoop RK, Cremers FPM. 2008. Leber congenital amaurosis: Genes, proteins and disease mechanisms. Prog Retin Eye Res 27: 391-419.
38. Dina C, MeyreD, Gallina S, Durand E, Korner A, Jacobson P, Carlsson LMS, Kiess W, Vatin V, Lecoeur C, et al. 2007. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39: 724-726.
39. Dipple KM, McCabe ERB. 2000. Phenotypes of patients with "simple" Mendelian disorders are complex traits: Thresholds, modifiers, and systems dynamics. Am J Hum Genet 66: 1729-1735.
40. Downes SM, Holder GE, Fitzke FW, et al. 2001. Autosomal dominant cone and cone-rod dystrophy with mutations in the guanylate cyclase activator 1a gene-encoding guanylate cyclase activating protein-1. Arch Ophthalmol 119: 96-105.
41. Drumm ML, KonstanMW, SchluchterMD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, et al. 2005. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 353: 1443-1453.
42. Dryja TP, McGee TL, Hahn LB, Cowley GS, Olsson JE, Reichel E, Sandberg MA, Berson EL. 1990. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. N Engl J Med 323: 1302-1307.
43. Ebermann I, Scholl HN, Charbel Issa P, Becirovic E, Lamprecht J, Jurklies B, Millán J, Aller E, Mitter D, Bolz H. 2007. A novel gene forUsher syndrome type 2: Mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss. Hum Genet 121: 203-211.
44. Ebermann I, Phillips JB, Liebau MC, Koenekoop RK, Schermer B, Lopez I, Schaefer E, Roux A-F, et al. 2010. PDZD7 is a modifier of retinal disease and a contributor to digenicUsher syndrome. J Clin Invest 120: 1812-1823.
45. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, Nadeau JH. 2010. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 11: 446-450.
46. Emison ES, McCallion AS, Kashuk CS, Bush RT, Grice E, Lin S, Portnoy ME, Cutler DJ, Green ED, Chakravarti A. 2005. A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature 434: 857-863.
47. Evans DM, Spencer CCA, Pointon JJ, Su Z, Harvey D, Kochan G, Oppermann U, Dilthey A, Pirinen M, Stone MA, et al. 2011. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 43: 761-767.
48. Fahim AT, Bowne SJ, Sullivan LS, Webb KD, Williams JT, Wheaton DK, Birch DG, Daiger SP. 2011. Allelic heterogeneity and genetic modifier loci contribute to clinical variation in males with X-linked retinitis pigmentosa due to RPGR mutations. PLoS ONE 6: e23021.
49. Felbor U, Benkwitz C, Klein ML, Greenberg J, Gregory CY, Weber BF. 1997. Sorsby fundus dystrophy: Reevaluation of variable expressivity in patients carrying a TIMP3 founder mutation. Arch Ophthalmol 115: 1569-1571.
50. Flint J, Mackay TFC. 2009. Genetic architecture of quantitative traits in mice, flies, and humans. Genome Res 19: 723-733.
51. Frank V, Ortiz Brüchle N, Mager S, Frints SGM, Bohring A, du Bois G, Debatin I, Seidel H, Senderek J, Besbas N, et al. 2007. Aberrant splicing is a common mutational mechanism in MKS1, a key player in Meckel-Gruber syndrome. Hum Mutat 28: 638-639.
52. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JRB, Elliott KS, Lango H, RaynerNW, et al. 2007. Acommonvariant in the FTOgene is associated with body mass index and predisposes to childhood and adult obesity. Science 316: 889-894.
53. Frio TR, Civic N, Ransijn A, Beckmann JS, Rivolta C. 2008. Two trans-acting eQTLs modulate the penetrance of PRPF31 mutations. Hum Mol Genet 17: 3154-3165.
54. Gabriel SB, Salomon R, Pelet A, Angrist M, Amiel J, Fornage M, Attie-Bitach T, Olson JM, Hofstra R, Buys C, et al. 2002. Segregation at three loci explains familial and population risk in Hirschsprung disease. Nat Genet 31: 89-93.
55. Garcia-Barceló M-M, Sham M-H, Lui VC-H, Chen BL-S, Song Y-Q, Lee W-S, Yung S-K, Romeo G, Tam PK-H. 2003. Chinese patients with sporadic Hirschsprung's disease are predominantly represented by a single RET haplotype. J Med Genet 40: e122.
56. Garred P, Pressler T, Madsen HO, Frederiksen B, Svejgaard A, Fiby N, Schwartz M, Koch C. 1999. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 104: 431-437.
57. Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2, Strange A, Capon F, Spencer CC, Knight J, Weale ME, Allen MH, Barton A, Band G, Bellenguez C, et al. 2010. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 42: 985-990.
58. Génin E, Feingold J, Clerget-Darpoux F. 2008. Identifying modifier genes of monogenic disease: Strategies and difficulties. Hum Genet 124: 357-368.
59. GeorgeND, Yates JR, Moore AT. 1995. X linked retinoschisis. Br J Ophthalmol 79: 697-702.
60. Gershoni-Baruch R, Nachlieli T, Leibo R, Degani S, Weissman I. 1992. Cystic kidney dysplasia and polydactyly in 3 sibs with Bardet-Biedl syndrome. Am J Med Genet 44: 269-273.
61. Gherman A, Davis EE, Katsanis N. 2006. The ciliary proteome database: An integrated community resource for the genetic and functional dissection of cilia. Nat Genet 38: 961-962.
62. Gibson G. 2012. Rare and common variants: Twenty arguments. Nat Rev Genet 13: 135-145.
63. Goh K-I, Cusick ME, ValleD, Childs B, Vidal M, Barabási AL. 2007. The human disease network. Proc Natl Acad Sci 104: 8685-8690.
64. Goldberg AFX, Molday RS. 1996. Defective subunit assembly underlies a digenic form of retinitis pigmentosa linked to mutations in peripherin/rds and rom-1. Proc Natl Acad Sci 93: 13726-13730.
65. Goss CH, Newsom SA, Schildcrout JS, Sheppard L, Kaufman JD. 2004. Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. Am J Respir Crit Care Med 169: 816-821.
66. Gouya LDJ, Lamoril J, Da Silva V, Beaumont C, Grandchamp B, Nordmann Y. 1996. Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. Am J Hum Genet 58: 292-299.
67. Gouya L, Puy H, Robreau A-M, Bourgeois M, Lamoril J, Da Silva V, Grandchamp B, Deybach J-C. 2002. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Nat Genet 30: 27-28.
68. Gouya L, Martin-Schmitt C, Robreau A-M, Austerlitz F, Da Silva V, Brun P, Simonin S, Lyoumi S, Grandchamp B, Beaumont C, et al. 2006. Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria. Am J Hum Genet 78: 2-14.
69. Grunnet LG, Brøns C, Jacobsen S, Nilsson E, Astrup A, Hansen T, Pedersen O, Poulsen P, Quistorff B, Vaag A. 2009. Increased recovery rates of phosphocreatine and inorganic phosphate after isometric contraction in oxidative muscle fibers and elevated hepatic insulin resistance in homozygous carriers of the A-allele of FTO rs9939609. J Clin Endocrinol Metab 94: 596-602.
70. Gusella J, MacDonald M. 2009. Huntington's disease: The case for genetic modifiers. Genome Med 1: 80.
71. Hafezi F, Steinbach JP, Marti A, Munz K, Wang ZQ, Wagner EF, Aguzzi A, Remé CE. 1997. The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo. NatMed 3: 346-349.
72. rd7/rd7 that suppress retinal degeneration and restore blue cone cells to normal quantity. Mamm Genome 19: 145-154.
73. Haldane J. 1941. The relative importance of principal and modifying genes in determining some human diseases. J Genet 41: 149-157.
74. Halpain S, Dehmelt L. 2006. The MAP1 family of microtubule-associated proteins. Genome Biol 7: 224.
75. Hamilton WK, Ewing CC, Ives EJ, Carruthers JD. 1989. Sorsby's Fundus Dystrophy. Ophthalmology 96: 1755-1762.
76. Heckenlively JR, Chang B, Peng C, Hawes NL, Roderick TH. 1993. Variable expressivity of rd-3 retinal degeneration dependent on background strain. In Retinal degeneration (ed. Hollyfield JG, Anderson RE, LaVail MM), pp. 273-280. Plenum, New York.
77. Heckenlively JR, Chang B, Erway LC, Peng C, Hawes NL, Hageman GS, Roderick TH. 1995. Mouse model forUsher syndrome: Linkage mapping suggests homology to Usher type I reported at human chromosome 11p15. Proc Natl Acad Sci 92: 11100-11104.
78. Hillian AD, Londono D, Dunn JM, Goddard KAB, Pace RG, Knowles MR, Drumm ML. 2008. Modulation of cystic fibrosis lung disease by variants in interleukin-8. Genes Immun 9: 501-508.
79. Hong H-K, Lass JH, Chakravarti A. 1999. Pleiotropic skeletal and ocular phenotypes of the mouse mutation congenital hydrocephalus (ch/Mf1) arise from a winged helix/forkhead transcription factor gene. HumMol Genet 8: 625-637.
80. Humphries MM, Kiang S, McNally N, Donovan MA, Sieving PA, Bush RA, Machida S, Cotter T, Hobson A, Farrar J, et al. 2001. Comparative structural and functional analysis of photoreceptor neurons of Rho2/2 mice reveal increased survival on C57BL/6J in comparison to 129Sv genetic background. Vis Neurosci 18: 437-443.
81. Ikeda A, Yin Zheng Q, Rosenstiel P, Maddatu T, Zuberi AR, Roopenian DC, North MA, Naggert JK, Johnson KR, Nishina PM. 1999. Genetic modification of hearing in tubby mice: Evidence for the existence of a major gene (moth1) which protects tubby mice from hearing loss. Hum Mol Genet 8: 1761-1767.
82. Ikeda A, Naggert JK, Nishina PM. 2002a. Genetic modification of retinal degeneration in tubby mice. Exp Eye Res 74: 455-461.
83. Ikeda A, Zheng QY, Zuberi AR, Johnson KR, Naggert JK, Nishina PM. 2002b. Microtubule-associated protein 1A is a modifier of tubby hearing (moth1). Nat Genet 30: 401-405.
84. Jacobson SG, Cideciyan AV, Iannaccone A, Weleber RG, Fishman GA, Maguire AM, Affatigato LM, Bennett J, Pierce EA, Danciger M, et al. 2000. Disease expression of RP1 mutations causing autosomal dominant retinitis pigmentosa. Invest Opthalmol Vis Sci 41: 1898-1908.
85. Johnson BA, Cole BS, Geisert EE, Ikeda S, Ikeda A. 2010. Tyrosinase is the modifier of retinoschisis in mice. Genetics 186: 1337-1344.
86. Kajiwara K, Sandberg MA, Berson EL, Dryja TP. 1993. Anull mutation in the human peripherin/RDS gene in a family with autosomal dominant retinitis punctata albescens. Nat Genet 3: 208-212.
87. Kajiwara K, Berson E, Dryja T. 1994. Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science 264: 1604-1608.
88. Katsanis N, Ansley SJ, Badano JL, Eichers ER, Lewis RA, Hoskins BE, Scambler PJ, DavidsonWS, Beales PL, Lupski JR. 2001. Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder. Science 293: 2256-2259.
89. Keen TJ, Himms MM, McKie AB, Moore AT, Doran RM, Mackey DA, Mansfield DC, Mueller RF, Bhattacharya SS, Bird AC, et al. 2002. Mutations in a protein target of the Pim-1 kinase associated with the RP9 form of autosomal dominant retinitis pigmentosa. Eur J Hum Genet 10: 245-249.
90. Kerem BS, Zielenski J, Markiewicz D, Bozon D, Gazit E, Yahav J, Kennedy D, Riordan JR, Collins FS, Rommens JM. 1990. Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci 87: 8447-8451.
91. Khanna H, Davis EE, Murga-Zamalloa CA, Estrada-Cuzcano A, Lopez I, den Hollander AI, Zonneveld MN, Othman MI, Waseem N, Chakarova CF, et al. 2009. A common allele in RPGRIP1L is a modifier of retinal degeneration in ciliopathies. Nat Genet 41: 739-745.
92. Kim RY, Fitzke FW, Moore AT, Jay M, Inglehearn C, Arden GB, Bhattacharya SS, Bird AC. 1995. Autosomal dominant retinitis pigmentosa mapping to chromosome 7p exhibits variable expression. Br J Ophthalmol 79: 23-27.
93. Klöting N, Schleinitz D, Ruschke K, Berndt J, Fasshauer M, Tönjes A, Schön MR, Kovacs P, Stumvoll M, Blüher M. 2008. Inverse relationship between obesity and FTO gene expression in visceral adipose tissue in humans. Diabetologia 51: 641-647.
94. Kremer H, van Wijk E, Märker T, Wolfrum U, Roepman R. 2006. Usher syndrome: Molecular links of pathogenesis, proteins and pathways. Hum Mol Genet 15: R262-R270.
95. Labrune M, Gaux JC, Brault B. 1974. The Laurence-Moon-Bardet-Biedl syndrome. Urographic signs. Ann Radiol 17: 385-389.
96. Landau J, Bromberg Y, Schorr J. 1949. Laurence-Moon-Biedl syndrome with mulitple congenital malformations of the urinary tract. Acta Med Orient 8: 205-210.
97. Laurence KM, James N, Miller M, Campbell H. 1980. Increased risk of recurrence of pregnancies complicated by fetal neural tube defects in mothers receiving poor diets, and possible benefit of dietary counselling. BMJ 281: 1592-1594.
98. Leitch CC, Zaghloul NA, Davis EE, Stoetzel C, Diaz-Font A, Rix S, Alfadhel M, Lewis RA, Eyaid W, Banin E, et al. 2008. Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome. Nat Genet 40: 443-448.
99. Li JB, Gerdes JM, Haycraft CJ, Fan Y, Teslovich TM, May-Simera H, Li H, Blacque OE, Li L, Leitch CC, et al. 2004. Comparative genomics identifies a flagellar and basal body proteome that includes the BBS5 human disease gene. Cell 117: 541-552.
100. Lim J, Hao T, Shaw C, Patel AJ, Szabó G, Rual J-F, Fisk CJ, Li N, Smolyar A, Hill DE, et al. 2006. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 125: 801-814.
101. Liu Q, Saveliev A, Pierce EA. 2009. The severity of retinal degeneration in Rp1h gene-targeted mice is dependent on genetic background. Invest Ophthalmol Vis Sci 50: 1566-1574.
102. Loewen CJR, Moritz OL, Molday RS. 2001. Molecular characterization of peripherin-2 and rom-1 mutants responsible for digenic retinitis pigmentosa. J Biol Chem 276: 22388-22396.
103. Louie CM, Caridi G, Lopes VS, Brancati F, Kispert A, Lancaster MA, Schlossman AM, Otto EA, Leitges M, Grone H-J, et al. 2010. AHI1 is required for photoreceptor outer segment development and is a modifier for retinal degeneration in nephronophthisis. Nat Genet 42: 175-180.
104. Lyon AN, Pineda RH, Hao T, Kudryashova E, Kudryashov DS, Beattie CE. 2014. Calcium binding is essential for plastin 3 function in Smn-deficient motoneurons. Hum Mol Genet 23: 1990-2004.
105. Maddox DM, Ikeda S, Ikeda A, ZhangW, Krebs MP, Nishina PM, Naggert JK. 2012. An allele of microtubule-associated protein 1A (Mtap1a) reduces photoreceptor degeneration in Tulp1 and Tub mutant mice. Invest Ophthalmol Vis Sci 53: 1663-1669.
106. Magro F, Peres E. 1970. Nefropathia do sindrome do Laurence-Moon-Bardet-Biedl. Revista Iberica de Endocrinologia 17: 243-253.
107. Marchini J, Donnelly P, Cardon LR. 2005. Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet 37: 413-417.
108. Margolin DH, Kousi M, Chan Y-M, Lim ET, Schmahmann JD, Hadjivassiliou M, Hall JE, Adam I, Dwyer A, Plummer L, et al. 2013. Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. N Engl J Med 368: 1992-2003.
109. McWilliam P, Farrar GJ, Kenna P, Bradley DG, Humphries MM, Sharp EM, McConnell DJ, Lawler M, SheilsD, Ryan C, et al. 1989. Autosomal dominant retinitis pigmentosa (ADRP): Localization of an ADRP gene to the long arm of chromosome 3. Genomics 5: 619-622.
110. Naash ML, Peachey NS, Li ZY, Gryczan CC, Goto Y, Blanks J, Milam AH, Ripps H. 1996. Light-induced acceleration of photoreceptor degeneration in transgenic mice expressing mutant rhodopsin. Invest Ophthalmol Vis Sci 37: 775-782.
111. Nakazawa M, Wada Y, Tamai M. 1998. Arrestin gene mutations in autosomal recessive retinitis pigmentosa. Arch Ophthalmol 116: 498-501.
112. Ness SL, Ben-Yosef T, Bar-Lev A, Madeo AC, Brewer CC, Avraham KB, Kornreich R, Desnick RJ, Willner JP, Friedman TB, et al. 2003. Genetic homogeneity and phenotypic variability among Ashkenazi Jews with Usher syndrome type III. J Med Genet 40: 767-772.
113. Nordström S, Thorburn W. 1980. Dominantly inherited macular degeneration (Best's disease) in a homozygous father with 11 children. Clin Genet 18: 211-216.
114. Ohlemiller KK, Hughes RM, Lett JM, Ogilvie JM, Speck JD, Wright JS, Faddis BT. 1997. Progression of cochlear and retinal degeneration in the tubby (rd5) mouse. Audiol Neurootol 2: 175-185.
115. Oprea GE, Kröber S, McWhorter ML, Rossoll W, Müller S, Krawczak M, Bassell GJ, Beattie CE, Wirth B. 2008. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 320: 524-527.
116. Otto EA, Loeys B, Khanna H, Hellemans J, Sudbrak R, Fan S, Muerb U, O'Toole JF, Helou J, Attanasio M, et al. 2005. Nephrocystin-5, a ciliary IQ domain protein, is mutated in Senior-Loken syndrome and interacts with RPGR and calmodulin. Nat Genet 37: 282-288.
117. Perrault I, Delphin N, Hanein S, Gerber S, Dufier J-L, Roche O, Defoort-Dhellemmes S, Dollfus H, Fazzi E, Munnich A, et al. 2007. Spectrum of NPHP6/CEP290 mutations in Leber congenital amaurosis and delineation of the associated phenotype. Hum Mutat 28: 416-416.
118. Poloschek CM, Bach M, Lagrèze WA, Glaus E, Lemke JR, Berger W, Neidhardt J. 2010. ABCA4 and ROM1: Implications for modification of the PRPH2-associated macular dystrophy phenotype. Invest Ophthalmol Vis Sci 51: 4253-4265.
119. Rachel RA, May-Simera HL, Veleri S, Gotoh N, Choi BY, Murga-Zamalloa C, McIntyre JC, Marek J, Lopez I, Hackett AN, et al. 2012. Combining Cep290 and Mkks ciliopathy alleles in mice rescues sensory defects and restores ciliogenesis. J Clin Ivest 122: 1233-1245.
120. Raychaudhuri S, Iartchouk O, Chin K, Tan PL, Tai AK, Ripke S, Gowrisankar S, Vemuri S, Montgomery K, Yu Y, et al. 2011. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet 43: 1232-1236.
121. Riazuddin SA, Shahzadi A, Zeitz C, Ahmed ZM, Ayyagari R, Chavali VRM, Ponferrada VG, Audo I, Michiels C, Lancelot M-E, et al. 2010. A mutation in SLC24A1 implicated in autosomal-recessive congenital stationary night blindness. Am J Hum Genet 87: 523-531.
122. Riise R, Andréasson S, Borgström MK, Wright AF, Tommerup N, Rosenberg T, Tornqvist K. 1997. Intrafamilial variation of the phenotype in Bardet-Biedl syndrome. Br J Ophthalmol 81: 378-385.
123. Rivolta C, Sharon D, DeAngelis MM, Dryja TP. 2002. Retinitis pigmentosa and allied diseases: Numerous diseases, genes, and inheritance patterns. Hum Mol Genet 11: 1219-1227.
124. Rubin BK. 1990. Exposure of children with cystic fibrosis to environmental tobacco smoke. N Engl J Med 323: 782-788.
125. Sakamoto K, McCluskey M, Wensel TG, Naggert JK, Nishina PM. 2009. New mouse models for recessive retinitis pigmentosa caused by mutations in the Pde6a gene. Hum Mol Genet 18: 178-192.
126. Samardzija M, Wenzel A, Naash M, Remé CE, Grimm C. 2006. Rpe65 as a modifier gene for inherited retinal degeneration. Eur J Neurosci 23: 1028-1034.
127. Sancandi M, Griseri P, Pesce B, Patrone G, Puppo F, Lerone M, Martucciello G, Romeo G, Ravazzolo R, Devoto M, et al. 2003. Single nucleotide polymorphic alleles in the 5′ region of the RET proto-oncogene define a risk haplotype in Hirschsprung's disease. J Med Genet 40: 714-718.
128. Sato M, Nakazawa M, Usui T, Tanimoto N, Abe H, Ohguro H. 2005. Mutations in the gene coding for guanylate cyclase-activating protein 2 (GUCA1B gene) in patients with autosomal dominant retinal dystrophies. Graefes Arch Clin Exp Ophthalmol 243: 235-242.
129. Sayer JA, Otto EA, O'Toole JF, Nurnberg G, Kennedy MA, Becker C, Hennies HC, Helou J, Attanasio M, Fausett BV, et al. 2006. The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4. Nat Genet 38: 674-681.
130. Schäffer AA. 2013. Digenic inheritance in medical genetics. J Med Genet 50: 641-652.
131. Scuteri A, Sanna S, Chen W-M, Uda M, Albai G, Strait J, Najjar S, Nagaraja R, Orrú M, Usala G, et al. 2007. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 3: e115.
132. Seddon JM, Yu Y, Miller EC, Reynolds R, Tan PL, Gowrisankar S, Goldstein JI, Triebwasser M, Anderson HE, Zerbib J, et al. 2013. Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet 45: 1366-1370.
133. Smemo S, Tena JJ, Kim K-H, Gamazon ER, Sakabe NJ, Gomez-Marin C, Aneas I, Credidio FL, Sobreira DR, Wasserman NF, et al. 2014. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507: 371-375.
134. Speilman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52: 506-516.
135. Stoetzel C, Laurier V, Davis EE, Muller J, Rix S, Badano JL, Leitch CC, Salem N, Chouery E, Corbani S, et al. 2006. BBS10 encodes a vertebrate-specific chaperonin-like protein and is a major BBS locus. Nat Genet 38: 521-524.
136. Stoetzel C, Muller J, Laurier V, Davis EE, Zaghloul NA, Vicaire S, Jacquelin C, Plewniak F, Leitch CC, Sarda P, et al. 2007. Identification of a novel BBS gene (BBS12) highlights the major role of a vertebrate-specific branch of chaperonin-related proteins in Bardet-Biedl syndrome. Am J Hum Genet 80: 1-11.
137. Tantri A, Vrabec TR, Cu-Unjieng A, Frost A, Annesley WH Jr, Donoso LA. 2003. X-linked retinoschisis: Report of a family with a rare deletion in the xLRS1 gene. Am J Ophthalmol 136: 547-549.
138. Tolarova M. 1982. Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip. Lancet 320: 217.
139. Valente EM, Silhavy JL, Brancati F, Barrano G, Krishnaswami SR, Castori M, Lancaster MA, Boltshauser E, Boccone L, Al-Gazali L, et al. 2006. Mutations in CEP290, which encodes a centrosomal protein, cause pleiotropic forms of Joubert syndrome. Nat Genet 38: 623-625.
140. Vanscoy LL, Blackman SM, Collaco JM, Bowers A, Lai T, Naughton K, Algire M, McWilliams R, Beck S, Hoover-Fong J, et al. 2007. Heritability of lung disease severity in cystic fibrosis. Am J Respir Crit Care Med 175: 1036-1043.
141. Venturini G, Rose AM, Shah AZ, Bhattacharya SS, Rivolta C. 2012. CNOT3 is a modifier of PRPF31 mutations in retinitis pigmentosa with incomplete penetrance. PLoS Genet 8: e1003040.
142. Wald NJ, Law MR, Morris JK, Wald DS. 2001. Quantifying the effect of folic acid. Lancet 358: 2069-2073.
143. Walia S, Fishman GA, Swaroop A, Branham KEH, Lindemena M, Othman M, Weleber RG. 2008. Discordant phenotypes in fraternal twins having an identical mutation in exon ORF15 of the RPGR gene. Arch Ophthalmol 126: 379-384.
144. Wang M, Lam TT, TsoMOM, Naash MI. 1997. Expression of a mutant opsin gene increases the susceptibility of the retina to light damage. Vis Neurosci 14: 55-62.
145. Weber BHF, Vogt G, Pruett RC, Stohr H, Felbor U. 1994. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet 8: 352-356.
146. Weleber RG, Carr RE, Murphey WH, Sheffield VC, Stone EM. 1993. Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene. Arch Ophthalmol 111: 1531-1542.
147. Wenzel A, Grimm C, Marti A, Kueng-Hitz N, Hafezi F, Niemeyer G, Remé CE. 2000. c-fos controls the "private pathway" of light-induced apoptosis of retinal photoreceptors. J Neurosci 20: 81-88.
148. Wenzel A, Grimm C, Samardzija M, Remé CE. 2003. The genetic modifier Rpe65Leu450: Effect on light damage susceptibility in c-Fos-deficient mice. Invest Ophthalmol Vis Sci 44: 2798-2802.
149. Wijesuriya SD, Evans K, Jay MR, Davison C, Weber BH, Bird AC, Bhattacharya SS, Gregory CY. 1996. Sorsby's fundus dystrophy in the British Isles: Demonstration of a striking founder effect by microsatellite-generated haplotypes. Genome Res 6: 92-101.
150. Zernant J, Külm M, Dharmaraj S, den Hollander AI, Perrault I, Preising MN, Lorenz B, Kaplan J, Cremers FPM, Maumenee I, et al. 2005. Genotyping microarray (disease chip) for Leber congenital amaurosis: Detection of modifier alleles. Invest Ophthalmolo Vis Sci 46: 3052-3059.
151. Zhang K, Kniazeva M, Hutchinson A, Han M, Dean M, Allikmets R. 1999. The ABCR gene in recessive and dominant Stargardt diseases: A genetic pathway in macular degeneration. Genomics 60: 234-237.
152. Zhang Y, Seo S, Bhattarai S, Bugge K, Searby CC, Zhang Q, Drack AV, Stone EM, Sheffield VC. 2014. BBS mutations modify phenotypic expression of CEP290-related ciliopathies. Hum Mol Genet 23: 40-51.
153. Zuk O, Hechter E, Sunyaev SR, Lander ES. 2012. The mystery of missing heritability: Genetic interactions create phantom heritability. ProcNatl Acad Sci 109: 1193-1198.